EBITDA: Income before interest, taxes, depreciation and amortization.
Mustang Bio, Inc. (MBIO) had EBITDA of $-0.89M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.76M |
|
-- |
|
-- |
|
$0.89M |
|
$-0.89M |
|
$0.12M |
|
$-0.76M |
|
$-0.76M |
|
$-0.76M |
|
$-0.76M |
|
$-0.76M |
|
$-0.76M |
|
$-0.89M |
|
|
EBITDA |
$-0.89M |
4.02M |
|
4.02M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$13.05M |
|
-- |
|
-- |
|
$13.05M |
|
$10.00M |
|
-- |
|
$0.15M |
|
$10.15M |
|
$2.89M |
|
$2.89M |
|
$2.89M |
|
4.38M |
|
| Cash Flow Statement Financials | |
$-2.73M |
|
$1.17M |
|
$7.38M |
|
$6.84M |
|
$12.66M |
|
$5.82M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.35% |
|
-26.35% |
|
-5.84% |
|
-26.35% |
|
$0.66 |
|
$-0.39 |
|
$-0.68 |
|